Janet Liang - 02 Mar 2026 Form 4 Insider Report for Oscar Health, Inc. (OSCR)

Role
President, Oscar Insurance
Signature
/s/ Melissa Curtin, Attorney-in-fact
Issuer symbol
OSCR
Transactions as of
02 Mar 2026
Net transactions value
-$99,796
Form type
4
Filing time
04 Mar 2026, 16:23:39 UTC
Previous filing
04 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Liang Janet President, Oscar Insurance 75 VARICK STREET, 5TH FLOOR, NEW YORK /s/ Melissa Curtin, Attorney-in-fact 04 Mar 2026 0001888381

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OSCR Class A Common Stock Award +106,458 +62% $0.000000* 278,985 02 Mar 2026 Direct F1, F2
transaction OSCR Class A Common Stock Sale $99,796 -7,453 -2.7% $13.39 271,532 02 Mar 2026 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The shares represent restricted stock units, which will vest quarterly in 12 equal installments beginning on June 1, 2026, subject to the reporting person's continuous service through each vesting date.
F2 Includes shares to be issued in connection with the vesting of one or more restricted stock units.
F3 The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.